Dose escalation with high-dose 3D-conformal radiotherapy (HD-3D-CRT) or low-dose 3D-conformal radiotherapy plus HDR brachytherapy (LD-3D-CRT
+
HDR-B) for intermediate- or high-risk prostate cancer: Early results of a prospective comparative trial
To access this article, please choose from the options below
PII: S1538-4721(09)00014-2
doi:10.1016/j.brachy.2009.03.008
© 2009 Published by Elsevier Inc.
